Annovis Bio, Inc.
Annovis Bio, Inc. (ANVS) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · ANVS · as of Jun 9, 2026
Activity summary
Buy transactions
19
P-Purchase only
Sell transactions
0
12 Months
Buy/Sell ratio
∞
Buy/Sell (by trades)
Overall sentiment
Annovis Bio, Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
ANVS insider buying and selling by quarter
ANVS insider selling · ANVS insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Active insiders
Most active in past 12 months · ANVS ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
ANVS executive sell shares · ANVS board member insider trading · ANVS insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| May 20, 2026 | Hoffman Michael B Director | Purchase | 54,933 | $104K | Form 4 |
| May 20, 2026 | Hoffman Michael B Director | Purchase | 18,849 | $34K | Form 4 |
| May 20, 2026 | Hoffman Michael B Director | Purchase | 2,562 | $4K | Form 4 |
| Apr 2, 2026 | Hoffman Michael B Director | Purchase | 713,800 | $1.50M⚡ | Form 4 |
| Dec 8, 2025 | Hoffman Michael B Director | Purchase | 15,000 | $64K | Form 4 |
| Dec 8, 2025 | Hoffman Michael B Director | Purchase | 30,000 | $130K | Form 4 |
| Nov 24, 2025 | Hoffman Michael B Director | Purchase | 28,096 | $117K | Form 4 |
| Nov 24, 2025 | Hoffman Michael B Director | Purchase | 415 | $2K | Form 4 |
| Nov 24, 2025 | Hoffman Michael B Director | Purchase | 9,200 | $35K | Form 4 |
| Nov 24, 2025 | Hoffman Michael B Director | Purchase | 1,489 | $6K | Form 4 |
| Nov 21, 2025 | Hoffman Michael B Director | Purchase | 10,000 | $35K | Form 4 |
| Nov 21, 2025 | Hoffman Michael B Director | Purchase | 10,000 | $35K | Form 4 |
| Nov 14, 2025 | Hoffman Michael B Director | Purchase | 15,000 | $32K | Form 4 |
| Oct 28, 2025 | Maccecchini Maria-Luisa President & CEO · Director | Purchase | 97,561 | $200K | Form 4 |
| Oct 28, 2025 | Hoffman Michael B Director | Purchase | 975,610 | $2.00M⚡ | Form 4 |
| Sep 10, 2025 | Bruck Claudine Director | Option | 7,142 | $1000 | Form 4 |
| Aug 29, 2025 | Hoffman Michael B Director | Award | 5,000 | $12K | Form 4 |
| Aug 29, 2025 | Hoffman Michael B Director | Award | 5,000 | $11K | Form 4 |
| Aug 29, 2025 | Hoffman Michael B Director | Award | 5,000 | $11K | Form 4 |
| Aug 19, 2025 | Hoffman Michael B Director | Award | 1,100 | $3K | Form 4 |
| Aug 19, 2025 | Hoffman Michael B Director | Award | 5,545 | $14K | Form 4 |
| Aug 19, 2025 | Hoffman Michael B Director | Award | 5,283 | $14K | Form 4 |
| Aug 19, 2025 | Hoffman Michael B Director | Award | 6,717 | $17K | Form 4 |
| Jun 16, 2025 | Walsh Andrew Vice President, Finance | Award | 500 | $1K | Form 4 |
| Jun 13, 2025 | Hoffman Michael B Director | Award | 1 | $3 | Form 4 |
Hoffman Michael B
Director
Date
Apr 2
Shares
713,800
Price
$2.10
Value
$1.50M ⚡
Maccecchini Maria-Luisa
President & CEO · Director
Date
Oct 28
Shares
97,561
Price
$2.05
Value
$200K
Hoffman Michael B
Director
Date
Oct 28
Shares
975,610
Price
$2.05
Value
$2.00M ⚡
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About ANVS insider trading
ANVS insider trades
Annovis Bio, Inc. (ANVS) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Hoffman Michael B (Director), Maccecchini Maria-Luisa (President & CEO · Director), Bruck Claudine (Director). Over the past 12 months, 5 insiders have filed transactions with the SEC. ANVS insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Annovis Bio, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
ANVS insider trading · 5 questionsThe insiders of Annovis Bio, Inc. (ANVS) include executives and directors such as Hoffman Michael B (Director), Maccecchini Maria-Luisa (President & CEO · Director), Bruck Claudine (Director), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026